AnalystsInsight

Christopher Mcgratty (KBW): Analyst Track Record and Price‑Target Accuracy

How often Christopher Mcgratty’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 864 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#392 rank (was #299)+4 new ratings (UCB, TRMK, WFC)

Key takeaways

  • Christopher Mcgratty ranks #379 of 1,000 analysts in Exent’s scoring (4.9★).
  • 64.5% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 133 days; 84.2% of calls were up 12 months later.
  • Most‑covered stocks: JPM, BAC, C, USB.
  • Free on Exent: Christopher Mcgratty’s full record, with ratings 3 days after publication.

Christopher Mcgratty’s track record at a glance

Christopher Mcgratty of KBW ranks #379 of the 1,000 analysts Exent scores, with a 4.9★ rating and a focus on financials. Over a 7‑year lookback, 64.5% of Christopher’s price targets were reached, 12.1 points above the 52.4% average across all analysts.

MetricChristopher McgrattyAll analysts
Price‑target hit rate64.5%52.4%
Median days to hit target133 days91 days
Calls up after 12 months84.2%64.0%
Median 12‑month return of calls+16.0%+13.4%
Hit rate, last 2 years65.3%—
Average worst drop after a call−11.2%—
Ratings in the sample864—
Stocks covered52—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetChristopher Mcgratty
Under 30 days8.8%
30–90 days23.0%
90–180 days35.8%
Over 180 days32.5%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Christopher Mcgratty covers most

StockRatings in the sample
JPM20
BAC20
C18
USB16
WAL15
MS15
WFC14
FITB14

In the past year Christopher’s ratings were 54% Buy, 46% Hold and 0% Sell.

Christopher Mcgratty’s latest ratings

DateStockActionRatingPrice target
Sep 16, 2026UCBReiterated: BuyBuy$41.00
Sep 16, 2026TRMKReiterated: HoldHold$50.00
Sep 15, 2026WFCReiterated: HoldHold$94.00
Sep 15, 2026FITBReiterated: HoldHold$60.00
Aug 31, 2026ZIONReiterated: HoldHold$75.00
Aug 26, 2026MVBFReiterated: BuyBuy$34.00
Aug 5, 2026CBCReiterated: HoldHold$32.00
Jul 30, 2026UMBFReiterated: BuyBuy$160.00
Jul 30, 2026BANCRated: BuyBuy$23.00
Jul 28, 2026COFReiterated: BuyBuy$290.00
Jul 27, 2026FLGReiterated: BuyBuy$17.00
Jul 24, 2026COLBReiterated: BuyBuy$35.00
  • Sep 16, 2026
    Stock
    UCB
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $41.00
  • Sep 16, 2026
    Stock
    TRMK
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $50.00
  • Sep 15, 2026
    Stock
    WFC
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $94.00
  • Sep 15, 2026
    Stock
    FITB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $60.00
  • Aug 31, 2026
    Stock
    ZION
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $75.00
  • Aug 26, 2026
    Stock
    MVBF
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $34.00
  • Aug 5, 2026
    Stock
    CBC
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $32.00
  • Jul 30, 2026
    Stock
    UMBF
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $160.00
  • Jul 30, 2026
    Stock
    BANC
    Action
    Rated: Buy
    Rating
    Buy
    Price target
    $23.00
  • Jul 28, 2026
    Stock
    COF
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $290.00
  • Jul 27, 2026
    Stock
    FLG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $17.00
  • Jul 24, 2026
    Stock
    COLB
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $35.00

Christopher’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Christopher Mcgratty’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Christopher Mcgratty ranks #379 of 1,000 with a 4.9★ rating. 64.5% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 84.2% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Christopher Mcgratty’s success rate is 68.7% by the ranking source and 64.5% by Exent’s price-target hit-rate backtest, with a median of 133 days to reach a target.

Christopher Mcgratty (KBW) covers 52 stocks, mostly in financials. The most frequently rated are JPM, BAC, C, USB, WAL.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.